2-(3,4-Dichloro-5-methoxyphenyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane, 98%, 1g

3-(1-((3,3-Diphenylpropyl)(methyl)amino)-2-methylpropan-2-yl) 5-methyl 2,6-dimethyl-4-(3-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate hydrochloride, 99+%, 5g

(R)-5-(HYDROXYMETHYL)-1-METHYLPYRROLIDIN-2-ONE, 95.0%, 250mg

2-Bromo-1,1,1-trifluoro-hexane, 1g

5-Methyl-2-(3-trifluoromethylbenzoyl)pyridine, 97.0%, 1g

4-(4-bromo-1H-pyrazol-1-yl)pyridine, 95.0%, 1g

4-Bromo-2-furoic acid, 95.0%, 10g

2-Methyl-6-nitro-1,2,3,4-tetrahydroisoquinoline, 97%, 1g

Thieno[3,2-b]thiophene-2-carboxylic Acid>98.0%(GC)(T)200mg

6-Chloro-[1,2,4]triazolo[4,3-a]pyridine, 95+%, 1g

Harpagoside, ROTICHROM® Working Standard, 50 mg, conditionnement en verre

4-Nitro-1,2-phenylenediamine Monohydrochloride [Sensitive reagent for the determination of Se by GC-ECD]>99.0%(T)5g

5-Sulfamoyl-furan-3-carboxylic acid ethyl ester, 95.0%, 500mg